In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65

To replace mechanical ventilation (MV), which represents the cornerstone therapy in severe COVID-19 cases, high-flow nasal oxygen (HFNO) therapy has recently emerged as a less-invasive therapeutic possibility for those patients. Respecting the risk of MV delay as a result of HFNO use, we aimed to ev...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Life (Basel, Switzerland) Ročník 11; číslo 8; s. 735
Hlavní autoři:	Kljakovic Gaspic, Toni, Pavicic Ivelja, Mirela, Kumric, Marko, Matetic, Andrija, Delic, Nikola, Vrkic, Ivana, Bozic, Josko
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Switzerland MDPI AG 23.07.2021 MDPI
Témata:	Biomarkers Chronic illnesses COVID-19 Evaluation HFNO in-hospital outcomes Mechanical ventilation Mortality Multivariate analysis Oxygen Patients Risk risk scores Subgroups Ventilators COVID-19 mechanical ventilation risk scores HFNO in-hospital outcomes
ISSN:	2075-1729, 2075-1729
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!